Drugnews|藥時事

MEDIGEN

基亞生物科技股份有限公司

3176 · TPEx-listed

MEDIGEN is a Taiwan TPEx-listed biotechnology company, as of 2026-11-01.

Pipeline

AssetTarget / mechanismStageIndicationRegionSource dateSource
OBP-301————2026-08-21Company disclosure
異體 Magicell-NK————2026-06-30Company disclosure

Key events

No verified events in the past twelve months.

Related Drugnews articles

No related articles in this language.